MedPath

EVOLUTION® Duodenal Stent for Duodenal or Gastric Outlet Obstruction Caused by Malignant Neoplasms

Completed
Conditions
Duodenal Obstruction
Gastric Outlet Obstruction
Interventions
Device: EVOLUTION® Duodenal Stent
Registration Number
NCT00991614
Lead Sponsor
Cook Group Incorporated
Brief Summary

The objective of this investigation is to compile clinical experience on the use of the Evolution® Duodenal Stent (Cook Ireland), a CE marked device intended for the palliative treatment of duodenal or gastric outlet obstruction and duodenal strictures caused by malignant neoplasms. It is not the goal to change the usual treatment practice of the investigator or the center, nor to collect information on uses outside the product's indications. Patients will be treated as per usual medical practices.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
110
Inclusion Criteria
  • Patients for whom this device would be chosen in standard practice
Exclusion Criteria
  • Patients for whom this device would not normally be chosen in standard practice

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
EVOLUTION® Duodenal StentEVOLUTION® Duodenal Stent-
Primary Outcome Measures
NameTimeMethod
Patency of the stent14 days
Secondary Outcome Measures
NameTimeMethod
Procedural success, implant duration, symptom resolutionup to 6 months

Trial Locations

Locations (6)

IRCCS Instituto Clinico Humanitas

🇮🇹

Milan, Italy

Westmead Hospital

🇦🇺

Sydney, Australia

Hopital Saint-Luc / CHUM

🇨🇦

Montreal, Quebec, Canada

U.O. Endoscopia Digestiva Chirurgica

🇮🇹

Rome, Italy

Institution for Clinical and Experimental Medicine

🇨🇿

Praha, Czech Republic

Erasmus MC University Medical Center

🇳🇱

Rotterdam, Netherlands

© Copyright 2025. All Rights Reserved by MedPath